title: Essential roles of dopamine D4 receptors and the type 1 adenylyl cyclase in photic control of cyclic AMP in photoreceptor cells.
abstract: Light and dopamine regulate many physiological functions in the vertebrate retina. Light exposure decreases cyclic AMP formation in photoreceptor cells. Dopamine D(4) receptor (D(4)R) activation promotes light adaptation and suppresses the light-sensitive pool of cyclic AMP in photoreceptor cells. The key signaling pathways involved in regulating cyclic AMP in photoreceptor cells have not been identified. In the present study, we show that the light- and D(4)R-signaling pathways converge on the type 1 Ca(2+)/calmodulin-stimulated adenylyl cyclase (AC1) to regulate cyclic AMP synthesis in photoreceptor cells. In addition, we present evidence that D(4)R activation tonically regulates the expression of AC1 in photoreceptors. In retinas of mice with targeted deletion of the gene (Adcy1) encoding AC1, cyclic AMP levels and Ca(2+)/calmodulin-stimulated adenylyl cyclase activity are markedly reduced, and cyclic AMP accumulation is unaffected by either light or D(4)R activation. Similarly, in mice with disruption of the gene (Drd4) encoding D(4)R, cyclic AMP levels in the dark-adapted retina are significantly lower compared to wild-type retina and are unresponsive to light. These changes in Drd4-/- mice were accompanied by significantly lower Adcy1 mRNA levels in photoreceptor cells and lower Ca(2+)/calmodulin-stimulated adenylyl cyclase activity in retinal membranes compared with wild-type controls. Reduced levels of Adcy1 mRNA were also observed in retinas of wild-type mice treated chronically with a D(4)R antagonist, L-745870. Thus, activation of D(4)R is required for normal expression of AC1 and for the regulation of its catalytic activity by light. These observations illustrate a novel mechanism for cross-talk between dopamine and photic signaling pathways regulating cyclic AMP in photoreceptor cells.
authors.affiliation: Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
authors.forename: Chad R
authors.initials: CR
authors.lastname: Jackson
authors.forename: Shyam S
authors.initials: SS
authors.lastname: Chaurasia
authors.forename: Hong
authors.initials: H
authors.lastname: Zhou
authors.forename: Rashidul
authors.initials: R
authors.lastname: Haque
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Storm
authors.forename: P Michael
authors.initials: PM
authors.lastname: Iuvone
mesh_terms: D000262:Adenylyl Cyclases / Q000502:physiology*; D000818:Animals; D002384:Catalysis / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism* / Q000502:physiology; D018492:Dopamine Antagonists / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010775:Photic Stimulation / Q000379:methods*; D010786:Photoreceptor Cells / Q000187:drug effects / Q000502:physiology*; D050638:Receptors, Dopamine D4 / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000502:physiology*
chemical_list: D018492:Dopamine Antagonists; D050638:Receptors, Dopamine D4; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; C106670:adenylyl cyclase 1